Medscape study finds a 3-fold increased risk of bleeding in acutely ill patients treated with Xarelto, as well as a 4-fold increased risk of major bleeding in patients with acute coronary syndrome (ACS).
November 21, 2013 – Medscape study findings
Announcement Date: November 21, 2013